Drug
DS 1971a
DS 1971a: highest development phase Phase 1, developed by Daiichi Sankyo. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Daiichi Sankyo
Trials
| Drug | Phase | Indication |
|---|---|---|
| DS-1971a NCT02190058 | Phase 1 | Healthy |
| DS-1971a suspension NCT02266940 | Phase 1 | Healthy |
Latest
No recent events.
Follow DS 1971a on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.